Details of the Drug Reposition

General Information of This Drug (ID: DMNELKW)

Drug Name
GEN-011   DMNELKW
Drug Type
Cell therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Non-small-cell lung cancer DISI0V1B 2C25 Phase 1 [1]
Melanoma DIS1RRCY 2C30 Phase 1 [1]
Squamous head and neck cell carcinom DIS0UVDG 2D60.0 Phase 1 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT04596033) TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy. U.S. National Institutes of Health.